BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,650.00
+70.00 (1.25%)
Last updated: Dec 19, 2025, 1:07 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 572.69 billion as of December 19, 2025. Its market cap has increased by 21.99% in one year.
Market Cap
572.69B
Enterprise Value
226.22B
Revenue
115.09B
Ranking
n/a
PE Ratio
4.87
Stock Price
5,650.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 572.69B, a decrease of -47.22%. That is a compound annual growth rate of -19.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 572.69B | 19.14% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.96T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.64T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.10T |